Concepedia

Publication | Open Access

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

DOIFull Paper Access

406

Citations

18

References

2015

Year

James M. Schuster, R. K. Lai, Lawrence D. Recht, David A. Reardon, Nina A. Paleologos, Morris D. Groves, Maciej M. Mrugała, Randy L. Jensen, Joachim M. Baehring, Andrew E. Sloan,
Neuro-Oncology

Abstract

This study confirms, in a multicenter setting, the preliminary results seen in previous phase II trials of rindopepimut. A pivotal, double-blind, randomized, phase III trial ("ACT IV") is under way.

References

YearCitations

Page 1